Polyethylenimine (PEI) has been used as a vehicle to deliver genes to cancer cells and somatic cells. In this study, cationic polymers of PEI were shielded with anionic polymers of hyaluronic acid (HA) to safely and effectively deliver genes into human mesenchymal stem cells (hMSCs). HA interacted with CD44 in the plasma membranes of hMSCs to facilitate the internalization of HA-shielded PEI/pDNA complexes. The HA-shielded PEI/pDNA nanogels were confirmed by size changes, -potential, and gel retardation assays. HA-shielded nanogels were easily internalized by hMSCs, and this was reduced by pretreatment with a specific monoclonal antibody that blocked CD44. By shielding PEI/pDNA complexes with HA, nanogels were easily internalized to hMSCs when it did not blocked by anti-CD44. These shielded nanogels were also easily internalized by HeLa cells, and this was reduced by pretreatment with an anti-CD44 monoclonal antibody. Following internalization of the SOX9 gene, chondrogenesis of hMSCs was increased, as determined by RT-PCR, real-time quantitative PCR, and histological analyses.
Introduction
The CD44 glycoprotein is a specific receptor located at the cell surface and plays crucial roles in multiple contexts, including cellcell binding, cell-matrix binding, cell movement, and cell homing (Bian et al., 2013; Guo et al., 2012; Nagase & Nakayama, 2013; Quintanilla, Asprer, Vaz, Tanavde, & Lakshmipathy, 2014; Wang et al., 2014) . CD44 in various types of stem cells functions in diverse activities, such as cell adhesion, migration, homing, proliferation, survival, and death Hanke et al., 2014; Kato et al., 2014; Lamb, Lisanti, Clarke, & Landberg, 2014; Lim et al., 2013; White, Nash, Kavanagh, Savage, & Kalia, 2013) . CD44 binds hyaluronan and hyaluronic acid (HA) via its N-terminus (Assmann, Jenkinson, Marshall, & Hart, 1999; Malhotra, Laursen, Willis, & Sim, 1993) .
Monoclonal antibodies against CD44 or the addition of soluble HA have been used to detect interactions between CD44 and HA (Campo et al., 2012; Zhou, Weigel, Fauss, & Weigel, 2000) . Inhibition of CD44 using specific antibodies or HA reduces the production of cytotoxic cells in bone marrow. Due to the multiple interactions of HA with cell surface molecules, HA-modified particles have been used to target drugs and genes for delivering into cells (Philipp, Zhao, Tarcha, Wagner, & Zintchenko, 2009; Yu et al., 2013a) . The use of HA-modified nanoparticles and nanogels for cancer treatment has been evaluated in cancer cell lines (Li et al., 2014; Platt & Szoka, 2008) .
In this regard, several studies have investigated CD44-mediated delivery of particles into cells using HA (Almalik et al., 2013a; Almalik et al., 2013b; Nasti et al., 2009) . Nanoparticles composed of HA can be used to easily deliver drugs into CD44-positive cancer via interactions with CD44, while conventional nanoparticles have focused on the delivery of antibodies or peptide conjugates into cancer cells (Choi, Jang, Kim, & Ahn, 2014; Cho et al., 2011; Tiwari et al., 2014) . HA-modified nanoparticles are easily internalized by CD44-positive cell lines, without eliciting cytotoxic effects (Gan et al., 2013) .
Furthermore, in recent years, HA has been used for cartilage tissue engineering using stem cells (Frith et al., 2014; Jung et al., 2014; Kim, Khetan, Baker, Chen, & Burdick, 2013) . The injection of cells complexed with various types of soft and biodegradable hydrogels into defect sites to promote cartilage formation has attracted much attention because it avoids the need for open surgery. Binding between CD44 and HA stimulates a cascade of signaling pathways that stimulate the differentiation of stem cells into chondrocytes (Toh, Lim, Kurisawa, & Spector, 2012; Wu et al., 2013) . Several studies have investigated the use of HA derivatives for cartilage tissue engineering (Gerard et al., 2005; Yu, Cao, Zeng, Zhang, & Chen, 2013b) . HA derivatives were chemically modified with alginate or fibrin gel matrices to generate a microenvironment suitable for scaffolds of chondrocytes or mesenchymal stem cells (Chung et al., 2011) . The addition of soluble HA reportedly triggers the proliferation and differentiation of chondrocytes (Hwang, Varghese, Li, & Elisseeff, 2011; Lu et al., 2013) .
The purpose of this study was to evaluate receptor-mediated gene delivery into human mesenchymal stem cells (hMSCs) using HA-modified nanogels. There are a few studies of the use of nanogels harboring ligands of specific receptors to deliver genes into stem cells (Levett et al., 2014) . In this study, surface-modified nanogels were prepared using various ratios of polyethylenimine (PEI) to HA. By increasing the PEI:HA ratio, HA-modified nanogels were readily internalized via receptors located in the plasma membrane. 
Materials and methods

2
Cell culture
Human MSCs (Cambrex, Walkersville, PT-2501, USA) were obtained from bone marrow harvested from proximal femur samples, removed during hip replacement surgery, from a 20-year-old male. The patient provided informed consent, and the local ethical committee approved the use of the sample for research. hMSC were cultured in Alpha-minimum essential medium (␣-MEM) supplemented with 10% fetal bovine serum (FBS; Thermo Fisher Scientific Inc., Waltham, MA, USA) and antibiotic-antimycotic solution (Life Technologies, Carlsbad, CA, USA) at 37 • C in a 5% CO 2 atmosphere. HeLa cells (American Type Culture Collection, Manassas, VA, USA) were cultured in Dulbecco's Modified Eagle's Medium (DMEM) (Thermo Fisher Scientific Inc., Waltham, MA, USA). The harvested cells were maintained in DMEM supplemented with 10% FBS and antibiotic-antimycotic solution at 37 • C in a 5% CO 2 atmosphere.
Preparing experimental procedures
Rhodamine isothiocyanate (RITC)-conjugated HA (R-HA)
Oligo-HA (50 mg, 8.62 mol) and RITC (5.55 mg, 10.34 mol) were dissolved in deionized water (DW, 10 mL) and DMSO (2 mL), respectively. Two reactant solutions were mixed and stirred at room temperature. After 12 h, the reaction solution was dialyzed using a dialysis membrane (Spectra/Por; mol. wt. cutoff size, 1000) against DW for 2 days. The final products were lyophilized.
2.2.2. Preparation of HA (Hyaluronic acid) shielded PEI/pDNA nanogels PEI/pDNA (EGFP; green fluorescent protein reporter gene) complex was prepared by mixing PEI and pDNA in HEPES-buffered saline, and shielded various HA ratio (ratio of the amine group in PEI to the carboxylic group in HA). The HA shielded PEI/pDNA nanogels were incubated for 10 min at room temperature. The HA shielded PEI/pDNA nanogels were prepared at the ratio PEI(pDNA):HA of 1:0.5-20.
Preparation of expression vectors
The full-length human SOX9 (hSOX9) cDNA was amplified from a hSOX9 clone (ATCC, Manassas, VA, USA). The EGFP-hSOX9 expression plasmid (pEGFP-SOX9) were generated by ligating the hSOX9 open reading frame into pEGFP-N3 (Clontech, Mountain View, CA, USA), which encodes a green fluorescent protein. The EGFP expression plasmid (pEGFP) was generated by ligating the EGFP open reading frame derived from pEGFP-N3 into pcDNA3.1/hyg (Invitrogen, Carlsbad, CA, USA). All plasmid constructs were verified by DNA sequencing.
2.3. Charaterization of HA shielded PEI/pDNA nanogels 2.3.1. Dynamic light scattering (DLS)
Particle sizes of HA shielded PEI/pDNA nanogels were determined by DLS. Measurements were carried out with Zeta Sizer Nano ZS apparatus (Malvern, Southborough, MA). Freshly prepared HA shielded nanogel suspensions (800 l) were placed in a cuvettes without dilution. The measurement was carried out using a 4 mW He-Ne laser (633 nm) as light source at a fixed angle of 173 • . Each size measurement included at least 12 runs. All measurements were carried out in triplicate, and the results were expressed as the mean size ± SD.
-Potential measurements
The -potential of pDNA, PEI, HA, and HA shielded PEI/pDNA nanogels were measured at room temperature by Zeta Sizer (Malvern, Southborough, MA). Samples were prepared in disposable capillary cells (DTS1070) without dilution. The measurements were performed under conditions of low ionic strength where the surface charge of the particles can be measured accurately. All measurements were carried out at 25 • C in triplicate, and the results were expressed as means ± SD.
Atomic force microscopy (AFM)
To obtain images about the substructure and morphology of HA shielded nanogels, AFM measurements were conducted on an NanoWizard I (JPK Instruments, Berlin, Germany) by high-resolution type of scanning probe microscope. Height measurements and surface roughness were obtained using NanoWizard AFM image analysis software (JPK Instruments, version 2.1).
Scanning electron microscopy (SEM)
The mean diameter, and surface morphology of HA shielded PEI/pDNA nanogel suspensions were characterized by FE-SEM. The morphology of HA shielded PEI/pDNA nanogels were observed at 3 kV using a scanning electron microscope (FE-SEM, S-4700, Hitachi, Japan).
Gel retardation assay
pDNA, HA, PEI/pDNA, and HA shielded PEI/pDNA nanogels were loaded in the well of 1% agarose gel containing ethidium bromide, which was applied to 100 V electrodes in 0.5× TAE buffer for 20 min. DNA bands were visualized and photographed using a UV trans-illuminator and Gel Doc imaging system (Bio-Rad Laboratorie, Hercules, CA, USA).
Cell viability
A quantitative colorimetric assay was performed using Cell Counting Kit-8 (Dojindo Molecular Technologies, Kumamoto, Japan) for the evaluation of cytotoxicity of pDNA, HA, PEI/pDNA, and HA shielded PEI/pDNA nanogels. Human MSCs was seeded at a density of 5 × 10 4 cells/well in 12-well plate and incubated for overnight in the 5% CO 2 incubator. hMSCs were treated HA, PEI, and HA shielded nanogels with PEI(pDNA):HA ratio of 1:0.5, 1, 2, 5, 10, and 20 for 6 h. The medium was then replaced with 1 mL of fresh medium containing 10% FBS, 1% antibiotics from each polyplex solution. After a 48 h incubation, the medium was replaced with 1 mL of the medium containing 10% FBS and 10% CCK-8, followed by incubation at 37 • C for additional 2 h. The absorbance values were measured by using VERSAmax microplate reader (Molecular Devices, Sunnyvale, CA, USA) at wavelength 450 nm, with each measurement repeated three times.
2.6. Cellular uptake 2.6.1. Interactions of CD44 with HA HeLa cells or human MSCs were seeded in 6-well plate at a density of 4 × 10 5 or 2 × 10 5 cells/well and incubated for 24 h. Then rinsed twice and pre-incubated for 1 h in 2 mL serum-free medium at 37 • C. Different ratio of PEI(pDNA): RITC conjugated HA (R-HA) were added to the cells. After 6 h, the cells were rinsed with PBS in order to remove free nanogels, trypsinized and analyzed by Guava EasyCyte System (Guava Technologies, Hayward, CA, USA) equipped with a 583/26 nm laser. The data shown are the mean fluorescent signals for 7000 cells.
HeLa cells or Human MSCs were seeded at a density of 2 × 10 5 cells/well in 6-well plate over cover-glass slide. Cells were incubated with R-HA shielded PEI/pDNA nanogels for 30 min, 1 h, 3 h, and 6 h at 37 • C. The cells were washed twice with cold PBS and fixed with 1% paraformaldehyde (PFA) for 1 h at 4 • C. The cells were washed twice with 1 mL PBS to remove 1% PFA and then incubated in DAPI for 2 min. Cells on cove-glass were mounted in aqueous mounting medium (Biomeda, Foster City, CA, USA) and observed with confocal microscopy (LSM 510 META, Zeiss). The fluorescence was monitored in three channels: FITC (for DiO cell-labeling solution, CellLight ® Early Endosomes-GFP, or Alexa Fluor ® 488 Goat Anti-Rabbit IgG (H + L) Antibody; excitation 488 nm, emission 518 nm), RITC (for R-HA nanogels; excitation 558 nm, emission 583 nm), and DAPI (for nucleic acid; 40,6-diamidino-2-phenylindole; excitation 358 nm, emission 461 nm). The magnification objective lens was 40×.
Anti-CD44 antibody blocking
hMSCs were pre-incubated for 2 h at 37 • C with 0.2 g/2 × 10 5 cells of monoclonal anti-CD44 antibody (Santa Cruz, CA, USA) diluted in Alpha-minimum essential medium (␣-MEM) prior to addition of R-HA shielded PEI/pDNA nanogels.
Transfection experiment
The hMSCs were plated in a 6-well (2 × 10 5 cells/well) plate, cultured at 37 • C under 5% CO 2 , and then rinsed twice with cold PBS and pre-incubated for 2 h with 1 mL Anti-CD44 blocking medium at 37 • C. After blocking, the culture medium was replaced with 2 mL of Opti-MEM medium and cells were treated with R-HA shielded PEI/pDNA nanogels at the different ratio of 1:1, 1:5, and 1:10 for 6 h. After 6 h incubation, 2 mL of culture medium with FBS was added into each well to replace the complete medium, and cells were further incubated for 48 h post-transfection. The transfection efficiency was calculated by the flow cytometry (Guava Technologies, Hayward, CA, USA), and fluorescence confocal microscopy (LSM 510 META, Zeiss).
Pellet culture
For preparation of each pellet, aliquots of 1 × 10 6 cells in 1 mL of defined medium were spun down at 1200 rpm for 3 min in a 15 mL conical tube. Pellets were divided into 3 experimental groups in the complete medium (containing 10% FBS, and 1% antibiotics) and cultivated at 37 • C, and 5% CO 2 for 21 days by changing the medium every 2 days.
Measurement of total DNA, and sGAG contents
For sulfated glycosaminoglycan assay (Blyscan TM ; Biocolor Ltd., Carrickfergus, UK), the samples (n = 5/group) were fully digested for 4 h at 65 • C in papain digestion solution. The GAG content was determined using a 1,9-dimethylmethylene blue dye (DMB). In brief, 1 mL of a papain-digested sample was incubated with 2 mL of DMB dye, and the reaction was observed on a spectrophotometer at 655 nm with chondroitin sulfate C (Sigma) used as a standard. The number of cells was determined by measuring the double-stranded DNA content using a PicoGreen assay (Molecular Probes, Eugene, OR), according to the manufacturer's instructions. The total amount of GAG was normalized against the total amount of DNA.
RT-PCR, and quantitative real-time PCR (qPCR)
After 3 weeks in pellet culture, total RNA was isolated from the cell pellet using the TRIzol ® (Invitrogen; Carlsbad, CA) in accordance with the manufacturer's instructions. Total RNA (0.5 g) was reverse-transcribed in a 20 l reaction using MMLV reverse transcriptase and random hexamers. The PCR reactions were conducted using 2X SeeAmp TM ACP TM Master Mix II (Seegene, Seoul, Korea) under the following conditions: 94 • C for 5 min followed by 35 cycles of 20 s of denaturation at 94 • C, 45 s of annealing at 57 • C-61 • C, and 45 s of extension at 72 • C. PCR products were confirmed on 1.2% agarose gel and visualized under UV light after ethidium bromide staining. All PCR primers were indicated in Table 1 .
Additionally, specific gene expression was measured via realtime PCR in an ExiCycler (Bioneer, Daejeon, Korea). In brief, 1 l of each cDNA was amplified in a 20 l PCR assay containing 1.5 mM MgCl 2 , 20 pM of each primer, and 1× Takara PCR Master Mix (Takara, Otsu, Japan). Samples were then subjected to the following conditions in an ExiCycler: initial denaturation at 94 • C for 10 min followed by 45 cycles of 94 • C for 40 s, 58 • C for 30 s, and 72 • C for 30 s. Relative quantification was calculated via the 2-delta delta ct (cycle-threshold) method. In order to confirm the amplification of specific transcripts, melting curve profiles were generated at the end of each PCR by cooling the sample to 40 • C and then heating it slowly to 95 • C while continuously measuring the fluorescence.
Western blot analysis
Transfected cells were lysed with RIPA cell lysis buffer (GenDE-POT, Barker, Texas, USA; 150 mM sodium chloride, 1% Triton X-100, 1% sodium deoxycholate, 0.1% SDS, 50 mM Tris-HCl, 2 mM EDTA, and 0.005% protease inhibitors). Protein concentration was determined using the BCA Protein Assay Kit. Equal amounts of protein (30-50 g/well) were loaded into 8-10% (w/v) SDS-polyacrylamide gels and electrophoresed at 80-100 V for 2 h. Proteins were transferred to membranes, which were subsequently blocked with 2.5% skimmed milk prepared in Tris-buffered saline containing 0.2% Tween 20 and incubated with primary antibodies against GFP (1:5000, Clontech Laboratories Inc.), ␤-actin (1:10,000, Sigma), SOX9, collagen type II (COL II; 1:3000; Chemicon, Temecula, CA, USA), and aggrecan (1:2000; Abcam, Cambridge, UK). Blots were developed using enhanced chemiluminescence reagents (GE Healthcare, Little Chalfont, UK).
Histological and immunohistochemical analysis of the pellet
After 21 days of culturing, cell pellets fixed in 4% paraformaldehyde (PFA) for 1 h. Samples were embedded in O.C.T. compound (Tissue-Tek 4583, Sakura Finetek, USA) and 8-m sections were cut. Hematoxylin and Eosin (H&E) staining of sections was done for evaluation of cell morphology in pellets. Sulfated glicosaminoglicans (GAG) were visualized by staining with Alcian Blue, and, Safranin-O for 15 min, and sections (8-m) were stained with von Kossa, and Alizarin Red-S for extracellular matrix calcification. Immuno-staining was performed using an anti-COL II (1:200), and anti-SOX9 (1:200) primary antibody. The sections were rinsed with PBS and treated with 4% PFA for 15 min, 0.1% Triton X-100 for 10 min, and 1% BSA in PBS for 10 min. After blocking, sections were applied as a primary antibody at 4 • C, for 2 h. And then rinsed with PBS and incubated with Alexa Fluor 488-conjugated anti-rabbit immunoglobulin G (Molecular Probes, Eugene, OR, USA). Samples were washed with PBS three times and incubated for 5 min with 1:500 DAPI (4 ,6-diamidino-2-phenylindole) stain. The cells were then examined under a Zeiss LSM 510 META confocal microscope (Carl Zeiss, Gottingen, Germany).
Statistical analyses
Student's t-test was used for all statistical analyses. * P < 0.05 and ** P < 0.01 were considered to be statistically significant.
Results
Characterization of HA-shielded nanogels
The sizes of various HA-shielded PEI/pDNA nanogels were measured by DLS. The nanogel size increased as the PEI:HA ratio increased (Fig. 1A, a, d, and g ). Nanogels with a PEI:HA ratio of 1:1 were approximately 70 nm (Fig. 1A, a) . For nanogels with a PEI:HA ratio of 1:5, the size increased to 120 nm (Fig. 1A, d ). Nanogels with a PEI:HA ratio of 1:10 reached 150 nm (Fig. 1A, g ). DLS analyses of the other nanogels (PEI:HA ratios of 1:0.5 and 1:2) are shown in Figure S2 .
We also observed the sizes of HA-shielded PEI/pDNA nanogels with various PEI:HA ratios by performing AFM and SEM. In both analyses, the size of nanogels increased as the PEI:HA ratio increased (Fig. 1, e, f, h, and i) . Furthermore, the sizes determined by AFM and SEM were consistent with those determined by DLS. HA-shielded PEI/pDNA nanogels were large when the ratio of PEI to HA was high (Fig. 1A, h and i) .
The tight complexation of pDNA with HA-shielded PEI showed that the surface charge of this complex differed from those of pDNA, HA, and PEI (Fig. 1B) . When more HA was added, the surface of the complexes became more negatively charged (Fig. 1B, c) . By contrast, the surface of the complexes was more positively charged when a low amount of HA was added (Fig. 1B, a) . This indicates that HA on the outer surface of PEI/pDNA complexes could interact with the CD44 receptor on hMSCs.
Uptake of HA-shielded nanogels by hMSCs
The uptake of HA-shielded PEI/pDNA nanogels by hMSCs was evaluated over 6 h ( Fig. 2A) . Nanogels with a PEI:HA ratio of 1:1, 1:5, and 1:10 were detected by fluorescence-activated cell sorting (FACS) ( Fig. 2A, a) . Nanogels with a PEI:HA ratio of 1:10 showed the highest uptake by hMSCs over 6 h (Fig. 2A) ; 98% of hMSCs internalized nanogels. We also evaluated the uptake of nanogels over time ( Fig. 2A, b) . Uptake of nanogels with a PEI:HA ratio of 1:10 increased over time up to 6 h. At 3 h, 68% of hMSCs had taken up these nanogels. This was markedly higher than the percentage of cells that had taken up nanogels at 6 h when the PEI:HA ratio was 1:5. This indicates that HA-shielded nanogels with a PEI:HA ratio of 1:10 easily entered hMSCs via binding to CD44 on the plasma membrane.
The uptake of R-HA-shielded PEI/pDNA nanogels by hMSCs was visualized by confocal laser microscopy (Fig. 2B) . Cell membranes were stained and then nanogels were added. The nanogels, which fluoresced red, easily entered hMSCs when the PEI:HA ratio was high (Fig. 3B, c) . The nanogels localized in the center of hMSCs, close to the nucleus (Fig. 2B, f) . However, nanogels with a low PEI:HA ratio did not easily enter hMSCs (Fig. 2B, a and b) and did not localize at the cell center (Fig. 2B, d and e) .
We examined the uptake of HA-shielded PEI/pDNA nanogels (PEI:HA ratio of 1:10) over time (Fig. 2C) . These nanogels were observed in the cytosol of hMSCs up to 6 h, and the intensity of cytosolic red fluorescence increased over time (Fig. 2C, k and l) .
To confirm that the uptake of HA-shielded PEI/pDNA nanogels was mediated by CD44, these receptors and nanogels were detected by FACS (Fig. 2D ) and confocal laser microscopy (Fig. 2E) . In these analyses, receptor-mediated internalization of nanogels was clearly observed. The CD44 fluorescence signal decreased as the PEI:HA ratio increased (Fig. 2D, d ). Receptor-mediated cellular uptake of nanogels was reduced when the PEI:HA ratio was low (Fig. 2D, b) .
Immunohistology was performed to assess receptor-mediated internalization of HA-shielded nanogels by hMSCs using specific antibodies against CD44 (green) and R-HA (red) (Fig. 2E) . High levels of fluorescence were detected in hMSCs treated with nanogels with a high PEI:HA ratio (Fig. 2E, d) . In hMSCS treated with nanogels with a low PEI:HA ratio, the intensity of green fluorescence was higher than that of red fluorescence (Fig. 2E, b) . This shows that HA-shielded nanogels entered hMSCs via CD44 receptors.
We also investigated the complexation of pDNA with PEI of a low molecular weight (1800 Da) and a high molecular weight (25,000 Da) (Fig. S1 ). The viability of hMSCs treated with nanogels generated using these two types of PEI did not differ (Figs. S1A and S3B).
Inhibition of CD44-mediated cellular uptake of HA-shielded nanogels
We examined nanogel uptake by CD44-positive hMSCs (Fig. 3) . CD44 is typically used to characterize mesenchymal stem cells. Thus, CD44-mediated delivery is an ideal means to target genes to hMSCs. Even nanogels with a low PEI:HA ratio were easily internalized (Fig. 3A, b) . Nanogels in which this ratio was high were rapidly taken up by hMSCs, as determined by confocal laser microscopy (Fig. 3A, e) . However, uptake of nanogels by hMSCs was highly dependent on the presence of CD44 on the plasma membrane (Fig. 3A, j and l) . Red fluorescence, indicative of R-HA, was not detected in the cytosol of hMSCs pretreated with an anti-CD44 antibody. This shows that hMSCs require CD44 on their plasma membranes to internalize HA-shielded nanogels.
We quantitated the level of nanogel uptake by hMSCs, with or without anti-CD44 antibody pretreatment. Cellular uptake of nanogels with a high ratio of PEI:HA was markedly decreased by pretreatment with an anti-CD44 antibody (Fig. 3B, e and f) . This pretreatment decreased the percentage of hMSCs that had taken up nanogels from 88.53% to 29.43% after 1 h (Fig. 3B, e) and from 96.32% to 35.44% after 6 h (Fig. 3B, f) .
Evaluation of the uptake of several types of HA-shielded nanogels by HeLa cells pretreated with an anti-CD44 antibody showed that CD44 on plasma membranes was required for this uptake (Fig. S2) . Thus, CD44 on plasma membranes greatly assisted the entry of HA-shielded nanogels into cells.
Gene transfection
hMSCs were treated with several types of HA-shielded nanogels and analyzed by FACS, Western blotting, and confocal laser microscopy (Fig. 4) . To determine the abilities of these nanogels to deliver genes to hMSCs, the EGFP gene was complexed with PEI and the resulting complexes were shielded with HA. The EGFP gene was easily delivered into hMSCs using HA-shielded nanogels; however, this was markedly inhibited by anti-CD44 antibody pretreatment (Fig. 4 A, f-h ). Anti-CD44 antibody pretreatment decreased the percentage of hMSCs expressing EGFP following HA-shielded nanogel treatment (PEI:HA = 1:10) from 39.23% to 16.34% (Fig. 4A) . However, anti-CD44 antibody pretreatment did not change EGFP expression in hMSCs treated with nanogels that were not shielded with HA (PEI alone) (Fig. 4A, a and e) . This shows that gene delivery using HA-shielded nanogels is dependent on CD44 at the plasma membrane.
Western blotting was performed to evaluate EGFP expression in hMSCs following treatment with several types of HA-shielded nanogels, with or without anti-CD44 antibody pretreatment. EGFP expression in hMSCs was blocked by pretreatment with an anti-CD44 antibody (Fig. 4B) . Anti-CD44 antibody pretreatment did not affect EGFP expression in hMSCs treated with nanogels that were not shielded with HA (PEI alone) (Fig. 4B, a and b) .
In immunohistological analyses, EGFP was clearly expressed in hMSCs treated with HA-shielded nanogels (Fig. 4C, b-d) . However, green fluorescence was markedly reduced in hMSCs pretreated with an anti-CD44 antibody (Fig. 4C, f-h ). Green fluorescence was not affected by anti-CD44 antibody pretreatment in hMSCs treated with nanogels that were not shielded with HA (PEI alone) (Fig. 4C,  a and e) . Thus, blockage of CD44 hindered the entry of HA-shielded nanogels into hMSCs. We tested the suitability of several types of HA-shielded nanogels as gene delivery vehicles (Figs. S3 and S4 ). Cells treated with nanogels with a PEI:HA ratio of 1:10 showed the highest levels of gene transfection and expression. The SOX9 gene is important for chondrogenesis of mesenchymal stem cells. Therefore, we attempted to deliver this gene into hMSCs to induce chondrogenesis. The SOX9 gene was tagged with EGFP and complexed with PEI, and the complexes were shielded with HA. The resulting nanogels were transfected into hMSCs and gene expression was evaluated over time by FACS (Fig. 5A) . After 72 h, hMSCs expressed EGFP-tagged SOX9, causing their differentiation into chondrocytes.
hMSCs treated with EGFP-tagged SOX9 gene-containing nanogels were visualized by confocal laser microscopy ( Fig. 5B ) and the level of EGFP was quantified (Fig. 5D) . EGFP-tagged SOX9 was clearly observed in hMSCs at 24 h (Fig. 5B, c) and was maintained up to 72 h (Fig. 5B, e) . The level of EGFP expression was maintained up to 72 h (Fig. 5D, f) .
hMSCs express SOX9 protein. Thus, we evaluated EGFP-tagged SOX9 protein in hMSCs over 72 h (Fig. 5C) . In Western blot analysis, exogenous and endogenous SOX9 proteins were detected as bands of 95 kDa and 72 kDa, respectively. In non-transfected cells, endogenous SOX9 was detected, whereas exogenous SOX9 was not detected at any time point (Fig. 5C, a-c) . In hMSCs transfected with HA-shielded nanogels containing the EGFP-tagged SOX9 gene, both endogenous and exogenous SOX9 proteins were detected (Fig. 5C, d-f) . Following transfection of the SOX9 gene, exogenous and endogenous SOX9 proteins were expressed to enhance chondrogenesis of hMSCs.
Transfection of the SOX9 gene into hMSCs to induce chondrogenesis
Following transfection of HA-shielded nanogels containing the SOX9 gene, hMSCs easily differentiated into chondrocytes. To detect chondrogenesis of transfected hMSCs, RT-PCR, real-time quantitative PCR, GAG content, and histological analyses were performed (Fig. 6) . During chondrogenesis of hMSCs, specific genes were expressed, including aggrecan, COMP, SOX9, and COL II (Fig. 6A ). These chondrogenesis-related genes were most highly expressed following treatment with HA-shielded nanogels containing the SOX9 gene. mRNA expression of these genes was highest following transfection of HA-shielded nanogels containing the SOX9 gene (Fig. 6B) .
The level of sGAG, an ECM component, was measured as an indicator of chondrogenesis (Fig. 6C ). Cells transfected with HAshielded nanogels containing the SOX9 gene produced significantly more sGAG than non-transfected cells.
To examine the ECM of hMSCs transfected with HA-shielded nanogels containing the SOX9 gene, polysaccharides and proteoglycans were stained with Alcian Blue and Safranin-O, respectively (Fig. 6D) . ECM calcium deposition, indicative of osteogenesis, was visualized by Alizarin Red-S and von Kossa staining (Fig. 6D) . Following transfection of HA-shielded nanogels containing the SOX9 gene, production of chondrogenesis-related and osteogenesis-related ECM components was increased and decreased, respectively.
At the protein level, the chondrogenesis-related proteins aggrecan, COL II, and SOX9 were highly expressed in hMSCs transfected with HA-shielded nanogels containing the SOX9 gene (Fig. 7A, c) .
The chondrogenesis-related proteins SOX9 and COL II produced by hMSCs were visualized by confocal laser microscopy (Fig. 7B) . Levels of these proteins were high following transfection of HAshielded nanogels containing the SOX9 gene (Fig. 7B, k-m) .
Discussion
In this study, we evaluated that the receptor-mediated gene transfection complexed with hyaluronic acid-modified nanoparticles were internalized into CD44+ receptor carrying human mesenchymal stem cells (hMSCs) (Nagase et al., 2013) CD44+ receptor which mainly located on the specific cell membrane has been to relate with several cell signaling including receptor-ligand reaction that is induced by multicellular organisms to cause the cell adhesion, proliferation, and cellular differentiation (Bian et al., 2013; Guo et al., 2012; Nagase & Nakayama, 2013; Quintanilla et al., 2014; Wang et al., 2014) . Cell adhesion starts in the progress of first cellular viable actions via links to the certain space interacted with receptors located in cellular membrane (Ke et al., 2014) . When the cells were cultured or transplanted in the condition of two dimensional culture system or wound site, they were led to search for the anchoring site to bind (Almeda, Wang, & Auguste, 2015) . This mechanism provokes the cell proliferation, growth, and differentiation.
In the case of capable gene delivery into cells, delivery vehicles have been recently developed as a direction of increasing the gene expression efficiency due to increasing their internalization as well as decreasing their cytotoxicity (Gerard et al., 2005; Yu et al., 2013b) . For these reasons, several types of carriers have been designed and selected biocompatible materials including organic and inorganic substance (Hwang, Varghese, Li, & Elisseeff, 2011; Lu et al., 2013) . Among them, the formations of nanostructure have been recently employed as the adequate shapes for the complexation with genes . To facilitate the gene delivery, nanostructured vehicles showed potential strong points for the internalization into cells via endocytosis (Park, Yang, Woo, Jeon, & Park, 2013a) . In previous studies, we developed the PLGA NPs coated with specific genes onto their outer surfaces which were tested for the vehicles for stem cell differentiation Park, Yang, Woo, Jeon, & Park, 2013b; Park, Yang, Woo, Jeon, & Park, 2012) . These nanostructured gene delivery vehicles clearly verified that the nanostructure formed PLGA NPs carrying specific genes increased their intracellular uptaking capability into human mesenchymal stem cells (hMSCs). By delivering the specific genes into cells effectively, the stem cells were easily switched into specific somatic cells in response to the internalization of SOX9, C/EBP-␣, and Runx2 genes, respectively.
In this study, we employed the HA-modified nanogels, which are consisting of specific biding sites for cells and complexing with anionic carrying pDNA. This system can be easily internalized into hMSCs via specific cell receptors of CD44+ which were abundance in stem cell membranes. For the evaluation of internalization of HA-modified nanogels, the RITC carrying them were tested by FACS analysis and confocal laser microscopy (Fig. 2) . To confirm the internalization of HA-modified nanogels mediated by CD44, inhibitors of receptors located in cell membrane were employed and also evaluated by FACS analysis and confocal laser microscopy (Fig. 3) . In these methods, receptor-mediated entering of HA-modified nanogels into hMSCs was clarified. Receptor-mediated cellular entering was increased when the HA-modified nanogels were used. However, their entering was reduced when the inhibitors of CD44 was pretreated into hMSCs (Fig. 3B, e and f) . It means that the internalization of nanogels into cells was increased by specific ligands of HA and reduced their internalization by pretreatment of anti-CD44 monoclonal antibodies.
In the case of gene transfection, the green fluorescence protein (GFP) plasmid DNA complexed in HA-modified nanogels was tested using hMSCs (Fig. 4) . For the detection of gene transfections into cells, we employed the Western blotting analysis for their protein expressions in cells. By internalization of HA-modified nanogels complexed with GFP genes, the expressions of GFP protein level by HA-modified nanogels complexed with GFP pDNA showed the high level by this analysis (Fig. 4A & B) . Also, the expression levels were reduced by inhibition of specific anti-CD44 pretreated cells. It means that the internalization of HA-modified nanogels complexes with genes were clearly increased via specific ligands of them and then released the genes into cytosol of cells for expression of specific proteins.
The stem cell differentiation was clearly evaluated by internalization of HA-modified nanogels which were complexed with SOX9 genes (Figs. 6 and 7) . By RT-PCR analysis, the chondrogenicrelated mRNA levels including aggrecan, COMP, SOX9, and collagen type II were highly expressed when the SOX9 genes were complexed with the HA-modified nanogels. When the SOX9 genes were complexed with PEI, the chondrogenic-related mRNA levels expressions were not highly detected (Fig. 7) . Also, in the amount of glycosaminoglycan (GAG) produced from hMSCs, the most important extracellular matrix (ECM) in cartilage tissue, there were some differences whether SOX9 gene transfected cells or not (Fig. 7C) . The SOX9 pDNA transfected hMSCs showed better GAG production. However, the original hMSCs did not produce the GAG. It means that the cells transfected with SOX9 gene were started to switch the chondrocytes.
Herein, we evaluated the chondrogenic differentiation of hMSCs by transfection of SOX9 genes complexed in HA-modified nanogels. In our guess, SOX9 genes are potential factors to induce chondrogenic differentiation. By transfection of SOX9 genes, specific ECMs, proteoglycan and polysaccharides, were highly produced from the hMSCs transfected with SOX9 pDNA whether complexed with PEI alone or HA-modified nanogels (Fig. 6D) . However, the osteogenic differentiation-related ECMs, calcium deposition, were not clearly detected in the case of SOX9 pDNA transfected hMSCs. This result was coincident with western blotting analysis and immunohistological analysis (Fig. 7A and B) . It means that the SOX9 pDNA complexed with HA-modified nanogels internalized into hMSCs and then the SOX9 pDNA released from HA-modified nanogels from endosome in cytosol of them. And these escaped pDNA entered into nucleus of hMSCs and then the hMSCs were switched into chondrocytes. The SOX9 pDNA showed quite influence the chondrogenic differentiation of hMSCs for their binding with HA-modified nanogels. It means that the SOX9 pDNA was quite easily entered into hMSCs when they were complexed with HA-modified nanogels.
Conclusions
In this study, HA-shielded PEI/pDNA nanogels were fabricated for receptor-mediated gene delivery into hMSCs. Cationic PEI can be complexed with anionic pDNA via electrostatic interactions, and other cationic moieties bind to anionic HA to form nanogels. HA-shielded PEI/pDNA nanogels can bind to CD44 on plasma membranes to deliver genes and stimulate stem cell differentiation. The size of nanogels and the ratio of PEI to HA can influence the efficiency with which HA-shielded PEI/pDNA nanogels enter hMSCs and deliver genes. Thus, we propose that HA-shielded PEI/pDNA nanogels can be used as gene delivery vehicles to induce stem cell differentiation.
